About this episode
If there’s one medication that’s got everyone talking it’s the antidiabetic medication semaglutide. The drug is often better known by one of its brand names, Ozempic, and it’s exploded in popularity mainly because of its weight loss effects. So what’s happened due to the popularity and what could be coming next?
Also, while COVID has become less relevant in everyday discussions it certainly hasn’t gone away. We haven’t seen the rise of a major new variant, but SARS-CoV-2 hasn’t been sitting still.
This week we’re joined by health reporters Tegan Taylor and Paige Cockburn.
Get every episode summarized
Each time The Science Show publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Science Show
Celebrating David Attenborough’s 100th birthday and a new way of making vaccines
The Science Show
Lab Notes: What happens if a major ocean current … stops?
The Science Show
Australian science under strain
The Science Show
Lab Notes: AI data centres are coming to remote Australia
The Science Show